NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CANC

Tema Oncology ETF

Jul 02 • 04:00PM ET

25.23

Dollar change +0.49
Percentage change 1.98	%

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-6.49%	Total Holdings	51	Perf Week	1.37%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	72.89M	Perf Month	3.49%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	7.59%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	29.85 -15.49%	Perf Half Y	2.26%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 25.55%	Perf YTD	3.79%
Active/Passive		Quant Type		Tags	-	Flows% 1M	3.15%	Volatility	2.08% 1.98%	Perf Year	-5.69%
Dividend TTM	0.50 (1.98%)	ESG Type		Tags	-	Flows% 3M	8.55%	ATR (14)	0.58	Perf 3Y	-
Dividend Ex-Date	Dec 11, 2024	Dividend Type		Sector/Theme		Flows% YTD	48.61%	RSI (14)	54.38	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.97	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	0.23%	Flows% 3Y		Rel Volume	1.27	Prev Close	24.74
Inverse/Leveraged		Market Cap		SMA50	3.09%	Flows% 5Y		Avg Volume	9.45K	Price	25.23
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	-1.38%	Trades		Volume	11,794	Change	1.98%

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience